Certain Postapproval Requirements and Resources for ANDAs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 4, 2026
June 4, 2026
114dc69b-dd6a-4c2f-88c6-0386cd92124f
Related Documents
Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs: Guidance for Industry
Guidance DocumentJuly 31, 2026Center for Drug Evaluation and Research
ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs: Guidance for Industry
Guidance DocumentDecember 16, 2025Center for Drug Evaluation and Research
Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use: Guidance for Industry
Guidance DocumentNovember 17, 2025Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.